Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing incidence of sexually transmitted infections (STIs)
3.2.1.2 Growing awareness and screening programs
3.2.1.3 Advancements in testing technologies
3.2.2 Industry pitfalls & challenges
3.2.2.1 Social stigma and under-reporting
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Future market trends
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Consumables
5.3 Instruments/Analyzers
Chapter 6 Market Estimates and Forecast, By Test Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Laboratory testing
6.3 Point-of-care (POC) testing
Chapter 7 Market Estimates and Forecast, By Technology, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Isothermal nucleic acid amplification technology
7.3 Polymerase chain reaction
7.4 Immunodiagnostics
7.5 Other technologies
Chapter 8 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals & clinics
8.3 Diagnostic laboratories
8.4 Home care setting
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 Becton, Dickinson and Company
10.3 binx health, inc.
10.4 Bioneer Corporation
10.5 Bio-Rad Laboratories, Inc.
10.6 Cepheid
10.7 ELITech Group
10.8 Genetic Signatures
10.9 Hologic, Inc.
10.10 Meridian Bioscience
10.11 Qiagen
10.12 Roche
10.13 Seegene, Inc.
10.14 Thermo Fisher Scientific, Inc.
10.15 VIRCELL S.L.
